about
Characterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyAssociation between physical activity, multimorbidity, self-rated health and functional limitation in the Spanish population.Global health care use by patients with type-2 diabetes: Does the type of comorbidity matter?Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study.[Deprescribing to increase people health or when deprescribing could be the best pill]Adherence to chronic medication in older populations: application of a common protocol among three European cohortsEffectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and GermanyHypovitaminosis D: Searching for the evidenceAdherence to treatment of hypertension, hypercholesterolaemia and diabetes in an elderly population of a Spanish cohort[Central serous chorioretinopathy secondary to Helicobacter pylori: To treat or not to treat, that is the question]Evolution of polypharmacy in a spanish population (2005-2015): A database studyHealth of Spanish centenarians: a cross-sectional study based on electronic health records
P50
Q33834390-4A8659E7-E78A-41E8-9C17-C838D2AEF01DQ34565396-9272CB16-B661-4889-9E38-66DB04BFA46EQ43330541-C16547AE-7824-488E-B4FF-BE98346E489CQ49964385-6A111F59-C840-4193-813A-88A16DC23107Q57064617-13D40437-F256-432F-A87A-7AD3FCD3A7AFQ57483256-01F4870E-3219-47E6-B5E5-BEBA51CB2C8BQ62023144-65CB55A3-F6DB-406F-AAB8-B87B4172A264Q89686983-F9A37420-0EB7-4F56-9B27-5C5062481BCBQ90020311-15F1668F-AB53-491E-ABDF-E74CB8C415ACQ90521283-9E3A871C-3379-411C-9CD1-30D37EB73788Q92458883-5035A7F3-B0CD-420E-93BE-7EABEE2FB751Q92704705-26126053-6803-467E-9438-8CBB09B9A55B
P50
description
researcher
@en
name
Francisca González Rubio
@en
type
label
Francisca González Rubio
@en
prefLabel
Francisca González Rubio
@en
P31
P496
0000-0001-5939-4436